AMRN
Amarin Corporation plc
NASDAQ · Healthcare · Biotechnology · IE
$13.63
−0.58%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.67x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.65x
- Price / sales
- 1.55x
- Price / cash flow
- 5.86x
Enterprise value
- Enterprise value
- -$21.5M
- EV / sales
- -0.12x
- EV / EBITDA
- 1.09x
- EV / EBIT
- 0.64x
- Market cap
- $287.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026